Multiscale engineering of microbial cell factories: A step forward towards sustainable natural products industry.

Microbial cell factories (bacteria and fungi) are the leading producers of beneficial natural products such as lycopene, carotene, herbal medicine, and biodiesel etc. These microorganisms are considered efficient due to their effective bioprocessing strategy (monoculture- and consortial-based approach) under distinct processing conditions. Meanwhile, the advancement in genetic and process optimization techniques leads to enhanced biosynthesis of natural products that are known functional ingredients with numerous applications in the food, cosmetic and medical industries. Natural consortia and monoculture thrive in nature in a small proportion, such as wastewater, food products, and soils. In similitude to natural consortia, it is possible to engineer artificial microbial consortia and program their behaviours via synthetic biology tools. Therefore, this review summarizes the optimization of genetic and physicochemical parameters of the microbial system for improved production of natural products. Also, this review presents a brief history of natural consortium and describes the functional properties of monocultures. This review focuses on synthetic biology tools that enable new approaches to design synthetic consortia; and highlights the syntropic interactions that determine the performance and stability of synthetic consortia. In particular, the effect of processing conditions and advanced genetic techniques to improve the productibility of both monoculture and consortial based systems have been greatly emphasized. In this context, possible strategies are also discussed to give an insight into microbial engineering for improved production of natural products in the future. In summary, it is concluded that the coupling of genomic modifications with optimum physicochemical factors would be promising for producing a robust microbial cell factory that shall contribute to the increased production of natural products.

Background

Green manufacturing industry, created from natural microorganisms, is a productive cell factory capable of valorizing polysaccharides (that are sourced from either plants or animals) into highly value-added natural products (NPs), such as flavonoid, carotenoid, and essential oil, etc. However, it is challenging to obtain a high yield due to involved stereochemical complexity [1]. Therefore, pretreatment methods before valorization have been investigated to overcome this bottleneck. Studies reveal that the optimum NPs production can be achieved by increasing microbial enzymes permeability that can be further enhanced by engineering microbial cells [2,3]. Generally, microbial-derived natural products exhibit lower water and land requirements and contribute as environmental benign (i.e., reduce global warming and pollution). Furthermore, these products are also cost-effective compared to products obtained from chemical plants. Normally, two major approaches, monoculture and consortial strategy, are adopted by microbial cells to produce diversified valuable products, as shown in Fig. 1 [4]. However, in the last decade, an increase in preference has been noticed for consortial systems because of higher production efficiency and fulfilment of more complicated processing tasks. Recently, a study on environmental biodiversity demonstrated the existence of 99% microorganisms in the form of consortia and highlighted their application areas such as wastewater treatment, bioremediation, composting, biomining, biofuel production and functional ingredients in the food industry [[5], [6], [7], [8]].

Fig. 1

Schematic diagram shows the multi-step technique leading to biosynthesis of natural products via monoculture and consortium bioprocessing strategies.

Apart from the evolution of microbial platforms to transform nearly any carbon source into the desired product, a rather modest number of these cases have seen the successful transition to industrial-scale marketed products. Moreover, the quality and titer of obtained products in the laboratory setting are lower than that of commercial setup; hence, several techniques (i.e., genetic engineering and process optimization) have been considered to proceed with the scale-up. Recently, multiple reviews have been written on process engineering practices but are limited to particular product scale-up in microbial production systems [[9], [10], [11]]. This review extensively focuses on physical (i.e., temperature, pH, inoculum ratio, and media composition) and genetic parameters that allow a better scale-up microbial NPs production. While, the comparison between two production schemes, including monoculture and consortium, shows system limitations regarding optimum product yield [12]. Secondly, the present review comprehensively assesses the monoculture and consortial systems and their syntrophic interaction identified by advanced synthetic techniques.

Primary microbial systems for sustainable NPs development

It is challenging for the microbiologists to identify and isolate novel producing microorganisms to meet the demand for natural products. It has been found that less than 5% of fungi and 1% of bacterial species are currently known, indicating still a large number of NP's synthetic microbial species to be discovered [13]. These natural products, especially polyphenols, flavonoids and carotenoids are characterized by an adequate level of antimicrobial and antioxidant properties comparable to or even better than many synthetic antioxidants. Additionally, therapeutic drugs and functional foods formulated with natural products have also been developed because of the less toxicity, cost-effectiveness, and surplus availability [14]. In general, there are approximately 1 million types of natural products that are simply categorized into bioactive and inactive compounds. Of these natural products, biologically active compounds are around 25%, while 60% have plant origin and the rest are from microbial sources. Meanwhile, the terrestrial environment seems to be ideal for the obtainment of natural products; approximately 129 bioactive natural products were collected from marine microbes from 2000 to 2003 [15].

Bacteria and fungi: a robust and efficient microbial factory

Particularly, fungi and bacteria possess stronger adaptation ability for every ecological niche, making them the largest kingdom globally. There are approximately 1.5 million known species of fungi, and only 10% of them are known to microbiologists that mostly undergo some sort of mutualistic relationships, such as mycorrhiza, lichen, and bifidobacterium (gut microbe). While, the examples of symbiotic nitrogen-fixing bacteria include rhizobium and azospirillum, which are mainly associated with plants [16,17]. Because of the complex ecosystem in an animal's intestine, a symbiotic relationship between gut microbiota and the host has been developed in which Bacteroidetes and Firmicutes make up 99% of the total gut population. Intriguingly, the existence of bacteria on earth dates back to over 3 billion years ago, and eukaryotes even existed for over 1 billion years. In terms of economic and ecological roles, specific bacterial and fungal families, such as Lactobacillaceae, Enterobacteriaceae, Saccharomycetaceae, and Agaricaceae, etc., have been well-recognized and also effectively contribute towards environmental benefits.

However, since the discovery of penicillin, more than 23,000 natural products (i.e., antivirals, antimicrobials, anti-inflammatory and cytotoxic agents, etc.) have been isolated [15]. Of these products, 42% are made from fungi (Basidiomycota and Ascomycota) and 32% by filamentous bacteria (actinomycetes with an average mass range of 200–3,000 Da) [18]. More importantly, some ascomycetes, such as Aspergillus, Pencillium and Fusarium species, are identified as a major source of valuable compounds, from which 950, 900, and 350 bioactive compounds have been isolated, respectively [19]. The development of new antibiotics is facing an increasing trend, as the human's fatalities by pathogenic microbes are progressively increasing. Because of the high quality and functionality, commercial antibiotics have been developed from fungi and bacteria, with the production proportion of 50, 15, 20% by the actinomycetes, non-filamentous bacteria and filamentous fungi, respectively [15].

Growing market demand for microbial derived NPs

According to Business Communication Company (BCC), global market for microbial products shows an increasing trend, from $143.5 billion in 2014 to $306 billion in 2020 [20]. Moreover, the latest technologies for the manufacturing of microbial products exhibit a higher degree of technical and economic advantages relative to simple synthetic processing. These microbial-derived products include nutrition supplements like amino acids and vitamins, secondary metabolites, organic acids, enzymes, coloring agents, flavoring agents, and therapeutic products (i.e., drugs, and antibiotics) [21]. Approximately 75% of antibiotics production in actinomycetes is majorly due to the single genus Streptomyces, which alone had a market of $25 billion in 2001 [22]. The market for antifungal drugs is expected to reach approximately $4 billion in 2002 [23]. The isoprenoid production seems to fluctuate over the time, the overall trend has been rising with hundreds of new structures being reported each year; while, markets for isoprenoids, including polyketides and terpenoids are $17 and $12 billion, respectively.

Monoculture as primitive and simpler strategy for bio-manufacturing

In environmental diversity, a single productive cell possesses the strong capacity to endure harsh physiological changes, including nutrient deficiency and negative biological interactions, by adopting the dormant strategy. Compared with the dormant state, the single culture exhibits increased potential growth in non-dormant mode but is more susceptible to predation [24]. However, metabolic control effect and microbial growth behavior also regulate the cell behavior primarily because of interacting intra- and extracellular chemical and physical parameters and due to the genetically encoded characteristics. There are several methods to identify the growth and behavior of single cell culture (i.e., known as monoculture). Of these, molecular and spectroscopic methods exhibit better results than conventional techniques. Meanwhile, it is challenging for the small percentages of monocultures to grow under severe environmental conditions, as they require controlled laboratory conditions after isolation and purification from environmental samples (e.g. water, soil, air, and animal gut) [25]. Till now, several studies have demonstrated the effect of various processing conditions, such as medium composition, incubation temperature, pH, and inoculum ratio, etc. on monoculture's growth and behavior profiles. However, this review aims to motivate the potential of utilizing consortium and monoculture as natural product sources and functional additives in the food and non-food industries, with the highlight on the effect of physical and genetic parameters on their optimal growth and production in subsequent sections [26].

Monoculture as a bio-manufacturing system for NPs

In industrial biotechnology, microbial strains isolated from nature are characterized by functional properties to execute the industrial NPs manufacturing process successfully. During process designing, the overall contribution of each microorganism also largely affects the plant and animal-derived natural products development. For instance, when comparison with non-model organisms, industrial natural products produced by model monocultures (i.e., E. coli and S. cerevisiae) are significantly higher, suggesting its simplified metabolic engineering and optimized bioprocess control [27]. Moreover, non-model organisms exhibit growth incompatibility at laboratory setting, but the recent advances in genome engineering technologies based on the combination of computational models, CRISPR/Cas tools, and synthetic biology methods, such as DNA assembly method are enabling their optimal growth in pre-defined laboratory model. Latter tools lead to rapid testing, construction, and characterization of genetic parts from different organisms [28]. With desired genetic characteristics, recombinant strains produce a higher level of natural products than nonrecombinant strains in an industrial setting, as displayed in Fig. 2 [29].

Fig. 2

Illustration of combinational strategy including, CRISPR gene editing tool, synthetic biology method (DNA assembly and automated sequencing) and computational modeling in nonmodel organisms for rapid testing, and construction, and characterization of recombinants genetic parts for improved production of natural products.

Furthermore, hydrolysis of polysaccharides via enzymes significantly enhances NPs, such as isoprenes, aromatic compounds, peptides, etc. These products have attracted tremendous manufacturer interests due to on-demand production and higher yield as well as controlled and scalable production in fermentation facilities; see Fig. S1, Supporting Information [30]. In terms of the application of monoculture as functional food additives, they can be simply categorized into GRAS (Generally Regarded as Safe) microbes (i.e., S. cerevisiae, and C. glutamicum etc.) and non-conventional GRAS microbes (Y. lipolytica), which is further positively correlated with the development of therapeutical and nutraceutical products [[31], [32], [33]]. Besides the well-known monoculture drawbacks, multiple reports have also demonstrated certain benefits, such as cost-effectiveness, simpler cultivation procedure, and robust method when compared to mixed culture [[34], [35], [36]].

Bio-synthetic tool assisted shift of monoculture system to consortium one

Recently, comprehensive assessments of activity and complexity of microbial systems have gained much attention in several scientific studies, which might be due to its association with the enhanced NPs production via monoculture and/or consortial based production set-ups. During symbiotic evolution, the monocultures that thrive under different environmental conditions usually adopt the traits of communities. Interestingly, a functional consortium comes into being by the interaction of several groupings of microorganisms, which indicates its wide range of specificity and complexity in structure than that of monoculture [4]. Thus, the multi-organism design (i.e. raceway ponds) could be a competitive alternative to traditional monoculture strategy, saving time and exhibiting resilience to fluctuating environmental conditions. This transition from static to dynamic programme is thought to be a result of synthetic biology tools that enable genetic engineering and DNA assembly methods to control organisms within consortia [37,38]. These tools consist of exogenous molecules to control population behaviors, to develop communication systems between consortial members via intercellular signalling, and to construct codependent links of microorganisms by syntrophic interactions.

Generally, biosynthesis of natural products via interactive approach is considered relatively difficult, mostly because of complex population dynamics, inter-modules metabolites transport, inappropriate precursors supply, different growth rate of both upstream and downstream modules, and long fermentation period [39]. Despite its limitations, recent researches have also demonstrated certain underlying consortium advantages that include increased substrates utilization spectra, lower metabolic stress through labor division approach, controlled intermediate products accumulation through changing strain–strain ratios, co-culture stability inside the fermentation reactors, reduced metabolite's production cost and by-product formation simultaneously [40,41].

Synthetic consortia as mimicking system from natural one

Since 1980, microbiologists aim to motivate the potential of utilizing community based activities (i.e., bioleaching, and degradation of pollutants) which are evolved from macro-to micro-sphere natural scenarios [42]. Recently, system biology tools have been introduced that determine the microbial community functioning and composition with the purpose to develop synthetic consortia [38,43]. The biological activities of microorganisms which are isolated from their natural communities have been widely reported. Meanwhile, in the laboratory, the unculturability of isolated strains might be due to niche mismatch, dormancy, antagonistic effects and obligate metabolic interactions. However, ‘unculturable’ indicates that present culturing techniques are not appropriate to grow a given microorganism in pure cultures under the laboratory setting [44]. Therefore, to resolve this problem microbial ecologists have adopted certain strategies such as selecting bacteria amenable to conventional culturing, and using culture-independent methods. In addition, many studies have shown that majority of these isolated strain prefer to grow as consortium rather than individual monocultures, and it is strongly indicating towards metabolic interactions in all possible combinations which might bring together strains that would not meet in their natural habitat [45,46].

In general, there are two major ways to procure microbial consortia involving either (i) a synthetic assembly obtained from scratch, or (ii) microbial community isolated from environmental samples [47]. Because of the high functional properties, natural consortia is commonly used to develop commercial food products, such as beverage and baked products, and also well-known for its role in some clinical studies [[48], [49], [50]]. Moreover, natural consortium synergism was commonly observed in herbivores’ gut and in bioleaching processing. It is mimicked by synthetic consortia, which leads to beneficial interaction for enhanced productivity of target natural products from cheap raw materials, such as lignocellulose wastes and animal manures; hence, no further acidic and enzymatic pretreatments are required [51,52].

Syntropic interaction in well-defined consortial system

Particularly, different members of microbial community that together respond well against industrial and environmental challenges in relative to monocultures, indicating the strong syntropic interaction among the diverse microorganisms like algae and bacteria [53,54]. It suggests that change in nutritional parameters affect the interaction pattern, which may be classified into two major types, either cooperative (symbiosis, mutualism, and commensalism) or non-cooperative interaction (parasitism, ammensalism and predation) [55]. Hence, cooperative interaction is practically important to achieve maximum beneficial outcomes in terms of valuable products quality and titer. In both cases, metabolic interactions exist along two main axes: (i) the investment by the involved partners (i.e. production cost of exchanged metabolite), and (ii) the degree of reciprocity (i.e. flow direction of metabolite). The microbial community is characterized by unique functional properties which emerge as a result of different interactions among inter-species. Moreover, shaping of function, structure, and dynamics of microbial communities have been aroused from inter-species interactions leading to the development of synthetic consortial system [56,57].

Spatially linked microbial consortia as a conceptual design to engineer consortia

It has been found that an enhanced control over the system (consortium) is achieved by applying a compartmentalization strategy that provides ideal settings compatible with the consortial members. Additionally, cross-feeding interactions influence the growth of consortial members in spatially linked microbial consortia (SLMC); while, it has been affected by certain factors, for example, regulation of biosynthesis enzymes, allocation of limited resources (e.g. expression machinery, nutrients, and space), and biotic composition of bacterial community, as well as certain ecological parameters like chemical diffusivity and degree of spatial structuring, etc. The transfer rate of metabolite is higher through membrane transport than diffusion-based transport, which also bears some risks, such as consumption of nutrients by third party, degradation and loss of exchanged metabolites by fast diffusion [58]. At the laboratory scale, several synthetic structures (e.g. nanotubes, channels, and pili) facilitate the attachment of bacterial communities in order to exchange the metabolites. Furthermore, Dietz et al. [59] used dialysis membrane reactor to exchange metabolites on either side of a membrane at a commercial scale. On the other hand, Hollow-fibre bioreactor provides similar growth conditions to co-culture on each side of separate bioreactors, as demonstrated in Fig. 3.

Fig. 3

Engineered laboratory (A) and commercial (B) scale approach to make consortium derived natural products under ideal growth conditions. At laboratory scale, microfluidic offers growing set of tools for manipulating the consortium growth under controlled environmental conditions, while hollow-fiber bioreactor is considered as commercial bioreactor, as it maintains the similar growth conditions for co-culture on each side of separate reactors.

Besides, spatial segregation coupled with in-line nutrient supplementation further improves the production of natural products. It has been considered an effective approach to retrieve consortial related drawbacks, such as growth inhibition by toxic intermediate compounds, inter-species dependency for nutrients, and lower product yield by downstream strains. Meanwhile, simple nutritional requirements are the key prerequisite characteristics for selecting upstream microorganisms limiting the metabolism interferences in downstream microorganisms. Moreover, the downstream microorganisms should possess some of the following characteristics: capable of co-habiting, matching growth rates, increasing the capability of upstream micro-organism to consume multiple feedstocks, nontoxic in nature, maintaining genetic integrity, and functioning as a bio producer [[60], [61], [62]].

Design and evaluation of consortial functioning by advanced synthetic technologies

Non-linearity in combination coupled with the immense complexity of microbial communities remains a major challenge to construct an efficient synthetic microbial consortium in which the role of each member is well-defined in the provision of community-derived fluxes under dynamic environments with varying physical and chemical conditions. The omics technology and genome-editing tools have gained much regard currently to achieve a rational design of synthetic microbial consortia. Omics tools arm researchers to have holistic views of growth dynamics and metabolic fluxes in defined consortia [63,64], but indicate a particular genetic pathway and interlinking between consortial members, leading to a consortium with the desired functional characteristics. Furthermore, the genetic-based treatments, such as transcriptional control, genome editing, and high-throughput mutagenesis significantly enhance the processing capabilities (i.e. enduring fluctuating reactor's environment, and producing optimum level of NPs) of synthetic microbial consortia, with more obvious improvement observed by CRISPR/Cas-based toolkits [[65], [66], [67]]. The aforementioned technologies such as omics and genetic engineering should be coupled to computer modelling to further contribute for a better understanding of microbial interactions [68,69]. Hence, comprehensive assessments of synthetic consortium structure, composition and functionality of consortial members are usually essential to promote their application in the industrial, medical, and environmental sectors [70,71].

Modern technique, including omics approach (transcriptomics, metabolomics, and proteomics), is one of the most robust, precise and efficient techniques (coupled with a higher level of detection limit) to analyze monoculture, environmental microbial communities, and defined consortia to understand the underlying molecular mechanisms of microbial interactions; see Fig. S2, Supporting Information [72,73]. Interestingly, by applying current metatranscriptomics and metaproteomics technologies, the obtained informative data are employed to compare the temporal gene expression between consortia and monocultures, such as temporal proteomes when complemented with the metabolomic analysis demonstrated the positive interaction between K. vulgare and B. megaterium to produce 2-keto-gulonic acid. In general, there are two major strategies for the selection of consortium members, the top-down method that considers consortium members as the keystone players isolated from specific complex microbial community [74], and the bottom-up method considering consortium members having desired traits and selected from the pool of engineered microorganisms [40]. Meanwhile, comparing the top-down method which is based on multiple omics analysis [[75], [76], [77]], the bottom-up method is more preferable for constructing the stable artificial microbial consortia, probably due to the rational guidance of genetic engineering principles with comprehensive analysis on system's genetic elements, circuits, modules, and metabolic pathways, as shown in Fig. 4 [78,79].

Fig. 4

Top-down (A) and bottom-up (B) approaches for synthetic consortia construction. In top down approach, the consortium members are isolated from complex microbial community, while in bottom up approach, consortium member are ascribed to specific traits and selected from pool of engineered microorganisms.

Several studies report that the process efficiency and ease to construct synthetic consortia via top-down approach is lower as compared to bottom-up strategy, which is mainly due to the unavailability of isolates, lack of genomic information, and suitable engineering tools for unconventional microorganisms. The bottom-up approach, which is facilitated by multiple synthetic biology tools, has thus been investigated for resolving this drawback to further lead in constructing robust and stable artificial consortia for the optimum production of NPs.

Optimum processing conditions for microbial bio-operational unit

Particularly, the biosynthetic strain behavior, either in consortium or in monoculture, is dependent on several factors, such as genomic (mutagenesis, and genetic engineering), and physicochemical parameters including media composition, incubation temperature, pH, and inoculation ratio etc. Microbial cell factory overall represents a valuable source of NPs, and these compounds are capable of meeting the requirements of value-added foods and therapeutic drugs of the local population [[80], [81], [82]]. Interestingly, the higher level of microbial NPs has been obtained by compatible physicochemical conditions coupled with desired genetic modification, and both of these are specific for various bacterial or fungal species [83,84]. There are several tools for recombinant geneticists, including genetic recombination, targeted duplication, and deletion by genetic engineering and transposition mutagenesis, to achieve the desired production of natural products [85]. Recent additions to these techniques include transcriptome analysis, metabolic engineering and genome shuffling. Moreover, this review aims to motivate the potential of utilizing monoculture and consortium for the optimum microbial NPs (e.g., lovastatin, and 3 aminobenzoic acid, etc.) production at a commercial scale, with the highlights on its compatible physicochemical conditions and desired genetic modulations, as displayed in Fig. 5. These parameters will be discussed herein.

Fig. 5

Multi-objective optimization of processing conditions and genomic engineering for enhanced production of microbial-derived natural products.

Effect of physical conditions on microbial derived-NPs production

In general, the microbial production of natural products and secondary metabolites is affected by external stimuli, i.e., the surrounding environment. Particularly, the microbial cell possesses the strong capacity to tolerate severe perturbation in environmental conditions. Considering the influence of environmental factors on microbial cells, it is possible to determine the most significant, as described in the following section.

Effect of temperature on microbial derived-NPs production

Many reports have shown that fermentation temperature can significantly affect microbial growth, specific enzyme activity, and enzyme folding [86]. Moreover, several temperature-related studies have also demonstrated its considerable impact on the production phases of NPs metabolism of microorganisms in monoculture and consortium and influence the interactions between various microbial groups [87,88]. In general, microorganisms are categorized into three major classes based on optimum growth temperature requirements: psychrophiles, mesophiles, and thermophiles. Psychrophiles, which grow as monoculture, appears to be an efficient source of novel metabolites, as they only perform under a certain temperature range of 0–15 °C. At the same time, these cold-adapted micro-organisms show enhanced adaptability against numerous stresses, like cold temperature stress, decreased fluidity of cell membrane, low nutrient availability, and transport protein efficiency [89]. Among the cold-adapted strains examined, the Penicillium griseofulvum exhibits increased fulvic acid, chanoclavine I, elymoclavine and mycelianamide production, all of which possess strong antimicrobial activity [90]. Additionally, Pseudogymnoascus sp. and Bacillus sp. are predicted to be among the most promising psychrophiles, based on their ability to produce higher concentrations of asteric acid derivatives and mixirins. These compounds are known to reduce fungal infection and proliferation of colon tumour cells, respectively [91,92].

More importantly, most monocultures prefer to grow and produce natural products at a moderate temperature range in between 20 and 45 °C. For example, Bacillus subtilis and Aspergillus sp. were cultured to produce optimum antifungal and insecticidal substances at a specific temperature, ranging from 25 °C to 37 °C as well as Aspergillus sp. also contributed in the production of aspochalasins antimalarial antibiotic [93]. A few findings have also been reported by Wiebe et al. 28, who demonstrated the microbial growth suppression by lack of substrate at minimum growth temperature (near 10 °C), which can be treated either by addition of substrates or rise in temperature [94]. Besides, Streptomyces thermoviolaceus, which grows as a thermophilic monoculture (from 40 °C to 55 °C) produced antibiotic granaticin and various extracellular proteins at a growth rate of 0.175 h-l at 45 °C [95].

A detailed study on the consortial growth behaviour during myeolchi-aekjeot (MA) fermentation demonstrates that the low temperature notably affects interaction among mesophilic bacterial communities and has adverse effects on microbial growth due to mycoplasma toxicity. Meanwhile, fermentation-derived amino acid production escalates many folds when the temperature is adjusted to 25–30 °C [96]. Anammox consortia, consisting of bacteria from phylum Chloroflexi, Chlorobi, and Proteobacteria, is a mesophilic consortium (20–25 °C), which is significantly linked to energy conservation strategy and capable of producing a higher level of amino acids [97]. Furthermore, the synthetic bacterial consortium consists of Streptomyces sp. and Methanosarcina sp. which have been recognized as a robust producer of actinorhodin (with an optimum growth between 25 °C and 37 °C) [98,99]. In shrimp fermentation, psychrophile community members exhibit a higher production of amino acids at 15 °C due to the growth inhibition of pathogenic strains (i.e., Vibrio, Aliivibrio, and Photobacterium sp.) after 105 days [100]. On the other hand, thermophilic methanogenic consortium TERIL63 was developed to produce a significant amount of volatile fatty acid (2037 mg/L), consisted of two strains, Methanothermobacter thermoautotrophicus and Thermoanaerobacter sp. It can grow in the wide range of 60–100 °C temperature in methogenic medium [101].

Effect of pH on microbial derived-NPs production

The pH level of the growth medium imposes selective pressure on microbial metabolism, growth, and secondary metabolites production. Interesting, both hydrogen and hydroxyl ions concentrations have an appreciable impact on microbial cell behaviour, or it may act indirectly by changing the degree of dissociation of valuable compounds in the growth medium. Hence, the pH variation largely impacts the enzymatic activity and normal nutrient solubility and influences the distribution of microorganisms in a diversified ecosystem [102,103]. In general, there are three major types of microorganisms, which are described as alkaliphiles, acidophiles, and neutrophiles on the basis of optimum pH requirement for growth. Importantly, microorganisms produce higher level of NPs at a wider range of pH (typically, most of the synthetic microbial cells prefer the pH range of 3–4 units) and pH variation remarkably affects the activity and composition of microbial community, indicating its significance more than temperature in certain industrial bioprocess (i.e. volatile fatty acid (VFA) production in bioreactor) [104].

For example, Bacteroides can adapt themselves over a wide range of pH rather than that of Streptococcus and Veillonella, which experience growth inhibition under acidic pH treatments [105]. Furthermore, in comparison with butyrogenic reactions (operated at acidic pH 5.5), propionate- and acetate-producing consortia, consisted of Veillonella, Escherichia, and Bacteroides, exhibited enhanced production of secondary matabolites at pH 6.5–6.9 (neutral pH) [106]. It has been found that basic mesophilic consortia, consisting of Bacteroidetes, Firmicutes, Actinobacteria, Tenericutes, Proteobacteria and Cyanobacteria, largely contributed in the production of longer chain VFAs at pH 9–10 and its yield was calculated up to 388 ± 28 mg VFA as HAceq g VS−1 added, where average composition comprises of 83% acetic acid, 6.3% propionic acid, 4.4% isovaleric acids, 3.6% isobutyric, and 2.7% n-butyric [104,107]. In addition, duckweed treatment via acidic mesophilic consortia (comprises of Bacteroidia, Gammaproteobacteria, and Clostridia) produces an appropriate level of volatile fatty acids; while, the optimization of processing conditions can further improve its yield. Later, genus Acidaminococcus, a mesophilic gram-negative cocci, is well determined for its amino acid production in acidic mesophilic fermenter [108].

In the case of monoculture, an increased selection has been noticed for both alkaliphile (i.e. B. aurantinus), and acidophile (i.e. A. terreus, and Streptomyces) to meet the demand of local population for antimicrobial products, such as aurantin, anti-influenza agent and secondary metabolites, etc., which are produced at pH value of 7.5, 6.4, and 5, respectively [109,110]. Aside from this, an appreciable level of granaticin antibiotic has been identified in the fermentation broth of S. therrnoviolaceus at pH 6.5–7.5 [111].

Effect of growth medium on microbial derived-NPs production

The prerequisite requirement for successful industrial fermentation is a good fermentation medium with a good nutritional profile, such as carbon, potassium, phosphorus, manganese, nitrogen, energy sources, etc. Also, some trace elements, including minimal salts, heavy metals and vitamins (growth factor), must meet the elemental needs for metabolite production and cell metabolism [112,113]. Thereafter, the high functional constituents in the medium serve as regulators which influence the quantity and type of metabolite produced during incubation. Moreover, it is important to determine the appropriate incubation period for the production of NPs because in a long incubation period, desired biologically active compounds convert into other less significant compounds. Cultivation medium can be simply categorized into complex media and minimal media. For instance, complex media exhibits higher cell density and microbial growth rates than minimal broth media, which has been widely reported for enhanced fatty acids, and sugars production [114].

As in monoculture, 2% of glucose supplementation appears as a superior substrate for higher antimicrobial metabolites production and cell growth in Streptomyces sp. RUPA-08PR and sucrose exhibit a similar pattern of result followed by xylose, mannose, and fructose, respectively [115]. However, it is not surprising to observe little antibiotic production in galactose and lactose supplemented medium due to its interference with microbial metabolism [116]. Particularly, the growth medium of B. subtilis is supplemented with glucose (40 g/L) and NH4NO3 (4.5 g/L), which positively contributes to enhanced surfactin production [117]. In the case of organic and inorganic nitrogen sources, yeast extract exhibited a higher yield of antimicrobial agents followed by peptone, NaNO3, beef extract, KNO3, etc. Meanwhile, 1% NaCl supplementation shows higher production of antimicrobial metabolites in various strains. Few studies have been reported that potato dextrose broth as an efficient growth medium, used to produce tropolone (antimalarial antibiotic) and cladospolide D (antifungal antibiotic) against Cordyceps sp. and Cladosporium sp., respectively [118].

Various cultivation media are identified in advanced microbial metabolomics studies, such as M9, minimal broth, universal 13C-labelled medium, nutrient broth, and Luria-Bertani broth [119]. It was found that too high substrate (phenanthrene, pyrene, and naphthalene) concentration cause toxicity to microbes, while low substrate concentration cannot meet the growth requirement of the microbial cell. Hence, selecting an ideal biosynthetic strain is necessary either by direct evolution or genetic engineering, allowing the microorganisms to co-utilize the multiple sugars in the cultivation medium [120,121]. A detailed assessment of consortia's co-utilization of various substrate mixtures demonstrates that engineered E. coli co-culture can co-utilize both xylose and glucose in a similar cultivation medium to produce flavonoid naringenin [122]. Moreover, in the fermenter, a periodic feeding of xylose, phosphate, and ammonium during the first 24 h, has been proved to optimize S. cerevisiae's growth in coculture to increase oxygenated taxane titer about threefold (16 mg/L in 90 h). Additionally, amino acids supplementation (i.e. Pro, Thr, Ile, Leu, and His) was added to the 2-Keto-d-gluconic acid producing consortium (G. oxydans-K. vulgare), which greatly improves 2-KGA (2-keto-l-gulonic acid) titer by 41.8% when compared to the original consortium (without amino acid supplementation) [123].

Effect of inoculation ratio on microbial derived-NPs production

Primarily, mixed synthetic communities are characterized by various kinds of species with varying growth rates in which the faster-growing species destabilizes other species through vigorous consumption of nutrients. Co-cultivation techniques have thus been investigated for resolving this drawback by optimizing the relative population ratio of microbial consortium either by varying the initial inoculum ratio or by inoculating a downstream strain during the culturing of upstream strain [[124], [125], [126]]. During fermentation, adjusting the initial inoculum ratio of upstream to downstream strains before strain cultivation could appreciably enhance population growth rate and specific performance of strains in the consortium. Moreover, population control strategies such as rational tuning of inoculation ratio among consortium partners should be applied to regulate overall production. For example, consortium with dominant ratios of upstream strains utilizes more substrates. However, it produces less final product rather than that of consortium with dominant downstream ratios, which exhibits decreased substrate utilization and enhanced final product production [124,127].

More importantly, the growth phase and inoculation timing are the important parameters that influence the consortium's performance and general structure. Generally, each growth phase (i.e., lag, log and stationary phase) associates with specific physiological changes which appear in the microbial cell [128]. A synthetic consortium, consisted of R. glutinis and C. vulgaris, displayed an enhanced lipid production (70.9%) at a ratio of 1:1 in their log phase. Besides, lipid producing consortia (Saccharomyces cerevisiae-Chlorella sp.) exhibits a higher level of metabolite production at ratio of 2:1 [129,130]. Additionally, a robust two member's consortium of Dinoroseobacter shibae strain and Thalassiosira pseudonana strain has been reported to provide higher metabolite yield when T. pseudonana is in exponential growth phase before the bacterial inoculation [131].

Meanwhile, it is challenging to achieve optimum production of β-carotene and flavonoids via synthetic consortia, such as Rhodotorula glutinis-Debaryomyces castellii (upstream:downstream) consortium and E. coli-E. coli consortium. Therefore, the adjustment of inoculum ratio at 1:1 and 8:2, respectively, have been investigated for enhanced production of β-carotene, and flavonoid [132,133]. It has been reported that the consortium's stability is negatively influenced by long fermentation period and large fermentation volume due to the incompatible growth requirements, metabolite dilution, and spatiotemporal dynamics inside the fermenter and thus, it is not surprising to exploit advanced genetic techniques to resolve these problems [134,135].

The inoculum density and age are now regarded as important parameters which influence the metabolite and biomass accumulation in monoculture as well as provide economic feasibility (in case of commercial fermentation) [136,137]. Bacillus subtilis SPB1, grown as a monoculture, provides an optimum lipopeptide yield (3.4 g/l) by adjusting second inoculum age and size to 4 h and 0.01, respectively, after a first inoculum age of 23 h [138]. In particular, glucose as a carbohydrate substrate increases the surfactin production in B. subtilis, which improves by optimum incubation time and inoculum size of 72 h and 1.5–2% (v/v), respectively. In B. braunii, maximum production of biomass and hydrocarbon up to 5.97 and 2.99 g m−2 day−1 can be achieved at controlled seed age and inoculum density of 14 days and 7.9–10.1 g m−2, respectively [139]. Finally, comprehensive assessments of physical requirements, including temperature, pH, medium composition, and inoculum density that are optimal for bacterial production, were conducted in Table 1.

Table 1

Effects of physico-chemical parameters on the production of natural products via monocultutre and consortial based system.

Physico-chemical parameters
Factor	Organism	Specifications		Production	Bioprocessing strategy		Reference
Temperature
33.7 °C	P. acidilactici	Observe bacterial growth at various temperature at a constant pH of 6.5No growth was seen at 10 °C, 50 °C		959.75 AU mL−1 Bacteriocin		Monoculture		[168]
37 °C	A. senegalensis	Enzymes speed up metabolismBacterial cells rapidly multiply		57 mg mL− 1Bacterial cellulose		Monoculture		[103]
37 °C	E. coli-E. coli	Heterologous enzyme folding and its activity in E. coli is dependent on temperature		1.5 mg/L3-amino-benzoic acid		Consortium		[169]
25–35 °C	Acinetobacter, Acetitomaculum,Bacillus	Mesophilic consortia operate well in acidogenic phaseMicrobial activity inhibited at 20 °C		4403 mg/LVolatile fatty acid		Consortium		[170]
pH
4.5	A. senegalensis	Carried out oxidative reactionAids nutrient solubility		98 mg mL− 1Bacterial cellulose		Monoculture		[103]
5.8–4.0	P. pastoris	Medium pH effect the chemical structure of end-products		60 mg/L &14.4 mg/L monacolin J, lovastatin		Monoculture		[171]
6.0	L. lactis-S. cerevisiae	pH control strategy without alkali supplementation was adapted		150.3 mg/LNisin		Consortium		[172]
6.0	L. lactis-K. marxianus	pH controlled by NaOH supplementationIn anaerobic cultivation, nisin production is higher as compared to aerobic conditions		98 mg/LNisin		Consortium		[173]
Medium composition
41 g/L fructose + 38 g/L peptone with HS medium	K. intermedius		Optimization of culture condition via response surface methodology (RSM)Fulfill nutritional requirement	3.906 g/L Bacterial cellulose		Monoculture		[174]
WB + BHM-YEP media	B. altitudinis J208		Optimization of culture condition through RSM based on central composite design (RSM-CCD)Cheap nutrient sourceHighly efficient and stable medium	60.1 L-1 h-1Xylanase11343 L-1 h-1Pectinase		Monoculture		[175]
55 g/L lactose + 15 g/L corn steep liquor + 5 g/L ammonium sulphate with MRS	Lactobacillus LMI8		Optimization of culture condition through RSMCost effectivenessHighly efficient source of medium	52.37 g/LLactic acid		Monoculture		[176]
Glucose 20 g/L + yeast extract 2.5 g/L + KH2PO4 1 g/L + MgSO4 0.5 g/L + (NH4)2SO4 0.05 g/L + FeSO4 0.01 g/L	T. maxima, P. carneus		Optimization of culture condition via Plackett–Burman experimental designMaximum laccase production on the 3rd day in co-culture 13Maximum MnP production on the 10th day in co-culture 15	12,382.5 U/mg proteinLaccase activity564.1 U/mg proteinMnP activity		Consortium		[177]
LB broth + antiboitics + sodium acetate + disodium malonate	E.coli-E.coli		Combination of modules I (Pc4CL2, VvSTS genes), IIc (S. coelicolor genes) and III (E.coli K-12 genes) generate piceatannol	124 mg/L (piceatannol)		Consortium		[178]
LB broth + antiboitics + disodium malonate	E.coli-E.coli		Combination of module I (Pc4CL2, VvSTS genes) with module II (two different gene sets) to generate resv	137 mg/L (resveratrol)		Consortium		[178]
Inoculum concentration/ratio
20%	A. senegalensis		Decrease competition between bacteria in consuming nutrientsPromote bacterial growth	395 g L− 1 Bacterial cellulose		Monoculture		[179]
1:2	P.pastoris-P. pastoris		Conversion capacity of intermediates was improvedDML and ML totally converted to MJ	93 mg/L monacolin J		Consortia		[171]
20:1	E. coli-E. coli		BW23 upstream module optimized for consolidated SAG productionBW downstream module designed for the conversion of SA to SAG	2500 mg/L salicylate 2-O-β-D-glucoside		Consortia		[180]
1:1	P.pastoris-P. pastoris		Ratio of P. p/FNsD_RFP_sAR should be optimizedDownstream LV module could match upstream DML module	24.6 mg/L lovastatin		Consortia		[171]

Abbreviation: HS medium, Hestrin-Schramm medium; WB, wheat bran; BHM-YEP, Bushnell Haas Medium-Yeast extract and Peptone; MRS, De Man, Rogosa and Sharpe; LB broth, Luria-bertani; SA, salicylate; SAG, salicylate 2-O-β-D-glucoside; DML, dihydromonacolin L acid; ML, monacolin L acid; LV, lovastatin.

Effect of genetic modifications on microbial derived-NPs production

As a robust natural product producer, genetically modified microorganisms (GMOs) have gained growing popularity in food, cosmetics, pharmaceutical, and many other industries. These microorganisms have been developed by engineering the genome on inserting and deleting desirable genes or pathways which will be discussed herein and also shown in Fig. 6.

Fig. 6

Overview of the various techniques, such as selection of suitable host, precursor engineering, pathway engineering and mutagenesis, employed in genetic engineering have led to the increased production of natural products.

Effect of heterologous host selection on microbial derived-NPs production

The optimum production of microbial-derived natural products, such as flavonoids, alkaloids, polyketides, and pharmaceutical products (i.e., antibiotic and antifungal drugs, etc.) have been widely reported via strain improvement, precursor supply engineering, pathway engineering, and mutagenesis. Interesting, deregulated organisms exhibit lower NPs production, probably due to the absence of appropriate biosynthetic enzymes. Thus genetic engineering (optimization of copy number and/or transcription frequency) is carried out in the suitable microbial host, including E. coli or S. cerevisiae, to resolve this low productivity issue [140]. However, an increased selection has been noticed for both Escherichia coli and Saccharomyces cerevisiae due to the availability of genetic manipulation tools, which are amenable to simple cultivation methods and production scale-up. Besides, other microorganisms, including Corynebacterium glutamicum and Streptomyces species have been extensively utilized as a heterologous host for NPs production [141,142].

Monoculture derived NPs have gained the growing popularity at commercial level because of its cost effectiveness and simpler cultivation protocols. Amorphadiene, an artemisinin precursor, has been produced by heterologous E. coli approximately 24 mg/L, by expressing S. cerevisiae's mevalonate pathway and synthetic amorphadiene synthase gene and its production will further improve up to 105 mg/L by optimization of processing conditions [143]. One additional avenue when selecting an appropriate host for NP production is to utilize co-culture (E. coli- S. cerevisiae) with components of a metabolic pathway split between distinct consortium's members to produce benzylisoquinoline alkaloids (BIAs) in which membrane-bound P450 enzymes expresses in upstream strain (S. cerevisiae) and (S)-reticuline biosynthesizes in downstream strain (E. coli), respectively [1,[144], [145], [146]]. Some examples of bioactive NPs derived from recombinant hosts have been shown in Table 2.

Table 2

Effect of genetic parameters on the production of natural products via monocultutre and consortial based system.

Genetic parameters
Factor	Organism	Specifications	Production	Bioprocessing strategy	Reference
Host selection	E. coli	Plasmid having tryptophan synthaseInduction with 3-indole acrylate	180 g L −1Tryptophan	Monoculture	[181]
Host selection	E. coli	Overexpression of heterologous crt genes (P. ananatis) & ispDF in DXP pathway	433 mg/LAstaxanthin	Monoculture	[182]
Host selection	E. coli-E. coli	Modular nature of co-culture engineering to rapidly identify a particular E. coli strain that markedly improved the efficiency of 3AB biosynthesis	48 mg/L3-amino-benzoic acid (3AB)	Consortium	[169]
Pathway engineering	E. coli	Integration of MVA and lycopene pathwayExtra copies of the idi gene	1.44 g/L Lycopene	Monoculture	[183]
Pathway engineering	E. coli	Combinatorial tuning of pathway enzymes (TAL, 4CL, CHS, CHI)Inducible promoter strengthsEnhancement of intracellular tyrosine supply	100 mg/L Naringenin	Monoculture	[184]
Pathway engineering	E. coli	Coupling of 3AB synthase, and PctV with the engineered shikimate pathwayT7 promoter enhances the expression of pathway enzymes	1.5 mg/L 3AB	Monoculture	[169]
Pathway engineering	Y. lipolytica	Introduction of β-carotene biosynthesis pathwayOptimization of upstream MVA pathway Downregulation of squalene synthaseOverproduction of astaxanthin synthesis	10.4 mg/L Astaxanthin	Monoculture	[185]
Pathway engineering	P. pastoris	Lovastatin and monacolin J production improved by 55% and 71% in consortial approachUpstream and downstream modules accommodate in two fluorescent strains	593.9 mg/L Monacolin J250.8 mg/L Lovastatin	Consortium	[171]
Pathway engineering	Three E. coli modules	Upstream strain produces pathway intermediate p-coumaric acidMidstream strain produces naringenin. Downstream strain converts naringenin into acacetin	20.3 mg/L Acacetin	Consortium	[186]
Precursor engineering	S. clavuligerus	Supply of 10 mM methyl oleate to bacteria carrying (MCM) pathwayEnhanced the conc. of methylmalonyl-CoA	17.8 mg/LFK506	Monoculture	[187]
Precursor engineering	E. coli	MEP pathway (B. subtilis), GPPS2 (A. grandis), MVA pathway are coexpressed	122.4 mg/L β-carotene	Monoculture	[188]
Precursor engineering	E. coli-E. coli	Co-culture enhance the availability of p-coumaric acid as a precursor for the production of sakuranetin	29.7 mg/L Sakuranetin	Consortium	[189]
Precursor engineering	E. coli-S. cerevisiae	E. coli excretes p-coumaric acid in mediumSaccharomyces cerevisiae expressing codon-optimized 4CL and STS for the conversion of p-coumaric acid into resveratrol	28.5 mg/L Resveratrol	Consortium	[190]
Precursor engineering	E. coli-E. coli	Upstream E. coli BL21 engineered to produce caffeic acid by expressing HpaBC, RgTALDownstream E.coli utilize caffeic acid to generate caffeoylmalic acid	570.1 mg/LCaffeoylmalic acid	Consortium	[191]
Mutagenesis	E. coli	Generation of GadB mutant (Glu89Gln/Δ452–466) upon pH shift	4.8 g/L of GABA	Monoculture	[192]
Mutagenesis	S.viridochromogenes	Mutation in ribosome protein S12 (rps12) through gene shuffling and ribosome engineering	1.4 g/L of Avilamycin	Monoculture	[193]
Mutagenesis	S. cerevisiae	25 min of UV exposureAddition of 20 mM Zinc sulphate	4.632 (v/v)Alcohol	Monoculture	[194]
Mutagenesis	S. cerevisiae	Express CrtZ (A. aurantiacum) and CrtW (B. vesicularis)Subjected to ARTP mutagenesis	217.9 mg/LAstaxanthin	Monoculture	[195]
Mutagenesis	E. coli-E. coli	ALE and ARTP mutagenesis coupled with efflux pump in the acquisition of pinene tolerant strain E. coli YZFP	166.5 mg/Lα-Pinene	Consortium	[196]

Abbreviation: MCM, methylmalonyl-CoA mutase; GABA, gamma-aminobutyrate; ARTP, Atmospheric and room-temperature plasma, ALE, Adaptive laboratory evolution; GPPS2, geranyl diphosphate synthase; MEP, methylerythritol 4-phosphate pathway, MVA, mevalonate pathway; 4CL, 4-coumarate-CoA ligase; STS, resveratrol synthase; TAL, tyrosine ammonia lyase; CHS, chalcone synthase; CHI, chalcone isomerase; DXP, 1-deoxy-d-xylulose-5-phosphate pathway; crt, carotenogenic gene.

Effect of precursor engineering on microbial derived-NPs production

After the host selection, strains exposure to the suitable genetic engineering techniques, such as overexpression of metabolic genes, gene deletion and replacement of existing enzymes with more active homologues have been proved to enhance the supply of biosynthetic precursors. This suggests the potent role of precursor supply engineering which can be achieved by manipulating either the enzymes (i.e., phosphoenolpyruvate carboxylase in E. coli and, Glc-6-phosphate dehydrogenase in S. cerevisiae) or pathway (i.e., NADPH and Malonyl-CoA generating pathway) participated in precursor supply [147,148]. As an example of precursors supply in monoculture, the addition of propionyl-CoA carboxylase coupled with propionate supplementation could further improve rapamycin and methylmalonyl-CoA titers upto 23.6 mg/L in the UV irridiated mutant S. rapamycinicus strain which is 3.2-fold higher than that of parental strain (7 mg/L) [149].

Aside from the overexpression of endogenous genes, an appreciable level of biosynthetic precursors can be achieved by the deletion of undesired side or competing pathways in the host. For example, the double deletion of ATF1 and OYE2 enzymes in strictosidine producing strain resulted in reduction of geraniol synthesis which could enhance the strictosidine production by 6-folds [150]. Meanwhile, in recent study, the two members consortium (E. coli-S. cerevisiae) has been investigated for resolving the problem of lower precursor supply during the taxanes production by carrying out oxygenation reaction in S. cerevisiae and enhancing taxadiene production in E. coli, leading to increased production of oxygenated taxanes (33 mg/L) [151,152]. Many reports have shown that precursor supply techniques have positive effects on optimum NPs production, shown in Table 2.

Effect of pathway engineering on microbial derived-NPs production

Metabolic pathway engineering comprises gene knockout, gene overexpression, and introduction of the functional genes capable of enhancing NP production [153]. Many studies have shown that deletion of genes can improve the yields of natural products, probably due to the elimination of competing pathways that involve unnecessary consumption of cellular resources. In the case of monoculture, the streptomycin gene cluster is introduced into the genome-minimized S. avermitilis (83% of its original size) and result in the maximum level of streptomycin titer when compared to parental strain carrying a similar heterologous gene cluster [154]. The overexpression of protein disulfide isomerase and actinorhodin gene cluster (4–12 tandem copies) greatly improves the production of Na-ASP1 protein and actinorhodin in P. pastoris and S. coelicolor, respectively [155,156]. Furthermore, compared with monoculture, the co-cultivation system possesses more flexibility and stability, leading to the optimum conversion of substrate to natural products [151].

As in the flavonoid synthesis pathway, six genes were split between the two modules, each carrying three genes, as per the co-factor requirement, i.e. NADPH and malonyl-CoA. This technique leads to enhanced flavan-3-ol production upto 40.7 mg/L, which is 970-fold higher than mono-cultivation system [37,157]. Meanwhile, the stability of engineered synthetic consortium (K. vulgare-G. oxydans) seems to be enhanced by knocking out specific metabolic genes and make it an ideal consortium for optimum production of 2-KGA (reached 89.7% within 36 h) against d-sorbitol [123]. Additionally, stable consortium and monoculture can be used to prepare amino acid, purine, antibiotics and fatty acid, as demonstrated in Table 2.

Effect of mutagenesis on microbial derived-NPs production

Mutation strategies have been utilized to procure overproducing cell lines that are resistant to environmental stress and toxic inhibitor [158]. Mutagenesis can be simply categorized into physical mutagenesis (e.g., by X-rays or ultraviolet light) and chemical mutagenesis (e.g., by ethyl methanesulfonate, nitrous acid, p-fluorophenylalanine or N-methyl-N′-nitro-N-nitrosoguanidine). Of these, p-fluorophenylalanine was employed to select overproducing cell lines with respect to phenolics [159]. As in fermentation industry, introduction of mutant strains of Brevibacterium, Serratia and Corynebacterium have been considered to improve the production of several natural products, such as antibiotics, amino acids, and nucleotides. Moreover, certain genetic techniques like protoplast fusion, and genomic shuffling are used extensively for strain improvement at industrial scale [[160], [161], [162], [163]]. Genome shuffling introduces a point mutations at a very low controlled rate which has been successfully improved the NPs titers in several strains like 130-fold increase in production of epothilone (104 mg/L) was observed in mutant strain of S. cellulosum GSUV3-205 in comparison with parental strain S. cellulosum So0157-2 (0.8 mg/L) [164].

Serratia marcescens, which grows as a monoculture, undergoes control mutation to achieve optimum production of threonine (25 g/l) and its titer was further improved up to 63 g/l by recombinant DNA technology [165,166]. Recently, a direct evolution technique is applied to microbial consortia to generate mutant strains of individual consortium members to construct productive consortia. For example, in mutated anammox consortium, the candidate genes in dominant organism Candidatus Kuenenia stuttgartiensis has been reported to efficiently perform certain tasks, such as the hydrazine metabolism and ladderane synthesis [167]. In addition, optimum productions of NPs were obtained via mutant strains have been demonstrated in Table 2.

Concluding remarks and future perspectives

This review emphasizes the significance of monoculture- and consortium-based bioprocessing approaches for the development of natural products that have gained popularity in many food and non-food industries because of their high yields, ease of optimization, economic feasibility, robust growth on inexpensive media, and stability. More importantly, these microbial-derived natural products are currently grabbing attention due to the rapid development of controllable consortia and monoculture through advanced genetic and process optimization techniques.

In particular, we briefly foreground some of the practical implementation of microbial consortium and a monoculture and some of the directions for future research that offer the potential of enhanced production yields and reduced processing costs. Potential directions include (i) development of inexpensive gene-chip assay and high-throughput screening tools that cause directed evolution in multiple communities (ii) in-depth understanding of microbial interactions (in case of a synthetic consortium), and metabolic networks to develop rational metabolic engineering design (iii) Advancement in omics approaches (such as transcriptomics and metabolomics) appears to be an effective way to quantify biochemical changes and metabolic mechanisms, as well as advances in metagenomics positively contributes to enhanced understanding of immensely diverse microbial sources, such as rivers, lakes, sub-seafloor sites, and ice cores. Ultimately, the scientific community will utilize advanced biotechnological data and computational models to achieve optimum natural products production via stable monoculture and consortium.

Declaration of competing interest

The authors declare no conflict of interest.